The risk of hepatocellular carcinoma is markedly increased in Gaucher disease

被引：0
|
作者：
Basiri, Mohsen [1 ]
Ruan, Jiapeng [2 ]
Nair, Shiny [3 ]
Lau, Heather A. [4 ]
Mistry, Pramod K. [5 ]
Taddei, Tamar [6 ]
机构：
[1] Yale Sch Med, Internal Med, New Haven, CT USA
[2] Yale Univ, Internal Med Dept, Med Sch, New Haven, CT USA
[3] Yale Univ, New Haven, CT USA
[4] Yale Univ, Internal Med, Weston, CT USA
[5] Yale Univ, Dept Pediat GI Hepatol, Sch Med, New Haven, CT USA
[6] Yale Sch Med, New Haven, CT USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2022.107022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
39
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [41] INCREASED RISK OF HEPATOCELLULAR CARCINOMA IN DIABETICS WITH NASH: UNOS DATABASE ANALYSIS
    Doycheva, Iliana B.
    Zhang, Talan
    Amjad, Waseem
    Thuluvath, Paul J.
    HEPATOLOGY, 2019, 70 : 222A - 223A
  • [42] INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND THERAPY OF TYPE 2 DIABETES MELLITUS
    Perciaccante, A.
    Balbi, M.
    Casarin, P.
    Zanette, G.
    Donadon, V.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S296 - S296
  • [43] Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome
    Kasmari, Allison J.
    Welch, Amy
    Liu, Guodong
    Leslie, Doug
    McGarrity, Thomas
    Riley, Thomas
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06): : 746.e1 - 746.e7
  • [44] Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma
    Wu, J. S.
    Chen, Y. P.
    Wang, L. C.
    Yang, Y. J.
    Deng, C. W.
    Hou, B. X.
    He, Z. L.
    Chen, J. X.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02) : 3812 - 3818
  • [45] Markedly elevated liver enzymes in the absence of hepatocellular disease
    Roy, A.
    Odimegwe, A.
    Abu Hassan, F. I.
    Al-Bayati, M.
    McMaster, K.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S86 - S86
  • [46] No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson's disease during long term follow up
    van Meer, Suzanne
    de Man, Robert A.
    van den Berg, Aad P.
    Houwen, Roderick
    Linn, Francisca
    Siersema, Peter D.
    van Erpecum, Karel J.
    HEPATOLOGY, 2014, 60 : 427A - 428A
  • [47] IS HIGH AGNOR QUANTITY IN HEPATOCYTES ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR-CARCINOMA IN CHRONIC LIVER-DISEASE
    DERENZINI, M
    TRERE, D
    OLIVERI, F
    DAVID, E
    COLOMBATTO, P
    BONINO, F
    BRUNETTO, MR
    JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (08) : 727 - 729
  • [48] Potential increased risk of renal carcinoma in Fabry disease
    Subadra, W. M.
    Wanninayake, S.
    van Dussen, Laura
    Ochoa-Ferraro, Antonio F.
    Dawson, Charlotte
    Langeveld, Mirjam
    Geberhiwot, Tarekegn
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02)
  • [49] Gaucher disease: risk stratification and comorbidities
    Beaton, Brendan
    Sierra Monzon, Jose Luis
    Hughes, Derralynn A.
    Pastores, Gregory M.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (11): : 839 - 846
  • [50] Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease
    de Fost, M.
    Langeveld, M.
    Franssen, R.
    Hutten, B. A.
    Groener, J. E. M.
    de Groot, E.
    Mannens, M. M.
    Bikker, H.
    Aerts, J. M. F. G.
    Kastelein, J. J. P.
    Hollak, C. E. M.
    ATHEROSCLEROSIS, 2009, 204 (01) : 267 - 272
12345